Publications by authors named "Y G Cordeiro"

Prion diseases are characterized by the misfolding and conversion of the monomeric prion protein (PrP) to a multimeric aggregated pathogenic form, known as PrP. We and others have recently shown that biomolecular condensates formed via liquid-liquid phase separation of PrP can undergo maturation to solid-like species that resemble pathological aggregates, and this process is modulated by DNA, RNA, and oxidative conditions. Conversely, the most well-studied ligand of PrP, copper ions, induce liquid-like condensates of PrP that accumulate Cuin vitro, and live PrP-expressing cells show condensation at the cell surface as triggered by physiologically relevant conditions of Cu and protein concentrations.

View Article and Find Full Text PDF

The protozoan parasite Trypanosoma brucei possesses a large family of transmembrane receptor-like adenylate cyclases (RACs), primarily located to the flagellar surface and involved in sensing of the extracellular environment. RACs exhibit a conserved topology characterized by a large N-terminal extracellular moiety harbouring two Venus Flytrap (VFT) bilobate structures separated from an intracellular catalytic domain by a single transmembrane helix. RAC activation, which typically occurs under mild acid stress, requires the dimerization of the intracellular catalytic domain.

View Article and Find Full Text PDF

Parkinson's disease (PD) is a multifaceted disease characterized by degeneration of nigrostriatal dopaminergic neurons, which results in motor and non-motor dysfunctions. Accumulation of α-synuclein (αSYN) in Lewy bodies is a key pathological feature of PD. Although the exact cause of PD remains unknown, accumulating evidence suggests that brain infiltration of T cells plays a critical role in the pathogenesis of disease, contributing to neuroinflammation and dopaminergic neurodegeneration.

View Article and Find Full Text PDF
Article Synopsis
  • - Alzheimer's disease (AD) is a serious global health challenge with no cure, marked by brain degeneration and cognitive decline; current treatments mainly manage symptoms rather than modify the disease itself.
  • - The accumulation of amyloid-β (Aβ) peptides plays a key role in AD pathology, and there's a shift in focus from targeting mature amyloid fibrils to addressing more toxic soluble Aβ oligomers that damage nerve cells and synapses.
  • - Natural products show promise in combating Aβ oligomer neurotoxicity through various strategies, suggesting they could lead to new, effective treatments for AD by understanding how they influence Aβ oligomer behavior in different experimental settings.
View Article and Find Full Text PDF

Oligomeric species of amyloid β peptide (Aβ) are pivotal in Alzheimer's disease (AD) pathogenesis, making them valuable therapeutic targets. Currently, there is no cure or preventive therapy available for AD, with only a few therapeutics offering temporary alleviation of symptoms. Natural products (NPs) are now considered promising anti-amyloid agents.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionno8sa527qlsputpjt314qpnfs8dp3cl1): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once